Gapping up
In reaction to strong earnings/guidance: EXFO +20.1%, WGO +4.8%, CAG +1.5%, BIG +1.4%, WOR +1.4%, ACN +1.1%, LEN +1%.
M&A news: AUXL +17.4% (QLT Inc and Auxilium Pharmaceuticals (AUXL) to merge), CJES +10.6% (entered into agreement to merge with Nabors Industries' (NBR) completion and production business in transaction valued at $2.86 bln), NBR +10.1% (confirmed agreement to combine its completion and production services business with C&J Energy Services (CJES)), AA +5.2% (confirms agreement to Acquire Firth Rixson to Grow Global Aerospace Portfolio for $2.35 bln in cash), .
Select oil/gas related names showing strength: GLNG +1%, PXD +0.8%, WNR +0.7%, PSX +0.7%, GLOG +0.4%, UNG +0.4%, EPD +0.4%.
Other news: UNXL +23.1% (achieves roll-to-roll pilot production of InTouch Sensors), IRM +21.6% (reports Favorable Private Letter Rulings Received from Internal Revenue Service; Iron Mountain expects its full-year 2014 annual distribution as a REIT to be $400 to $420 million), DRWI +16% (still checking), AGEN +14.9% (vaccine shows significant reduction in viral burden after HerpV generated immune activation), ROYL +11.3% (announced results of independent review of the prospective resource potential of two recently identified North Slope Alaska drilling targets), GLUU +4.9% (announces support for Google's (GOOG) Android TV and new game services), ICLD +4.9% (announces $3.95 mln managed services contract), ONVO +3.8% (still checking), BIIB +3.3% (light volume, following AUXL / QLTI merger news), EQIX +2.9% (on IRM REIT news), CLF +1.3% (issues letter to shareholders; says 'Casablanca's Short-term Agenda is Value Destructive in Current Pricing Environment'), MDT +1.2% (announced study results showing that continuous cardiac monitoring with the Reveal XT Insertable Cardiac Monitor was superior to standard of care).
Analyst comments: ZU +3.6% (upgraded to Outperform from Sector Perform at RBC Capital Mkts), FMS +2.7% (upgraded to Outperform from Neutral at Credit Suisse), PRXL +2.6% (upgraded to Outperform from Neutral at Robert W. Baird and upgraded to Outperform from Neutral at William Blair), HRC +2.1% (upgraded to Buy from Neutral at Goldman), HBIO +1.9% (initiated with a Buy at Janney), NUVA +1.8% (upgraded to Buy from Neutral at Goldman), TTWO +1.8% (upgraded to Buy from Hold at The Benchmark Company), BLMN +1.6% (initated with a Buy at Longbow), TWTR +1.4% (initiated with an Overweight at Barclays), FSC +1.1% (initiated with a Buy at Sun Trust Rbsn Humphrey), FB +0.9% (initiated with an Overweight at Barclays)
In reaction to strong earnings/guidance: EXFO +20.1%, WGO +4.8%, CAG +1.5%, BIG +1.4%, WOR +1.4%, ACN +1.1%, LEN +1%.
M&A news: AUXL +17.4% (QLT Inc and Auxilium Pharmaceuticals (AUXL) to merge), CJES +10.6% (entered into agreement to merge with Nabors Industries' (NBR) completion and production business in transaction valued at $2.86 bln), NBR +10.1% (confirmed agreement to combine its completion and production services business with C&J Energy Services (CJES)), AA +5.2% (confirms agreement to Acquire Firth Rixson to Grow Global Aerospace Portfolio for $2.35 bln in cash), .
Select oil/gas related names showing strength: GLNG +1%, PXD +0.8%, WNR +0.7%, PSX +0.7%, GLOG +0.4%, UNG +0.4%, EPD +0.4%.
Other news: UNXL +23.1% (achieves roll-to-roll pilot production of InTouch Sensors), IRM +21.6% (reports Favorable Private Letter Rulings Received from Internal Revenue Service; Iron Mountain expects its full-year 2014 annual distribution as a REIT to be $400 to $420 million), DRWI +16% (still checking), AGEN +14.9% (vaccine shows significant reduction in viral burden after HerpV generated immune activation), ROYL +11.3% (announced results of independent review of the prospective resource potential of two recently identified North Slope Alaska drilling targets), GLUU +4.9% (announces support for Google's (GOOG) Android TV and new game services), ICLD +4.9% (announces $3.95 mln managed services contract), ONVO +3.8% (still checking), BIIB +3.3% (light volume, following AUXL / QLTI merger news), EQIX +2.9% (on IRM REIT news), CLF +1.3% (issues letter to shareholders; says 'Casablanca's Short-term Agenda is Value Destructive in Current Pricing Environment'), MDT +1.2% (announced study results showing that continuous cardiac monitoring with the Reveal XT Insertable Cardiac Monitor was superior to standard of care).
Analyst comments: ZU +3.6% (upgraded to Outperform from Sector Perform at RBC Capital Mkts), FMS +2.7% (upgraded to Outperform from Neutral at Credit Suisse), PRXL +2.6% (upgraded to Outperform from Neutral at Robert W. Baird and upgraded to Outperform from Neutral at William Blair), HRC +2.1% (upgraded to Buy from Neutral at Goldman), HBIO +1.9% (initiated with a Buy at Janney), NUVA +1.8% (upgraded to Buy from Neutral at Goldman), TTWO +1.8% (upgraded to Buy from Hold at The Benchmark Company), BLMN +1.6% (initated with a Buy at Longbow), TWTR +1.4% (initiated with an Overweight at Barclays), FSC +1.1% (initiated with a Buy at Sun Trust Rbsn Humphrey), FB +0.9% (initiated with an Overweight at Barclays)